 | Amylyx Pharmaceuticals, Inc. | |||
| NMS : AMLX || Location: United States | ||||
$1.99-0.01 (-0.53%) |
0.53 M | 1.98 - 2.03 | ||
| Last Updated:America/New_York | Volume | Day range |
Short Interest
| Short Date | Short Interest |
|---|---|
| March 28, 2024 | 6.007 M |
| March 15, 2024 | 5.092 M |
| Feb. 29, 2024 | 4.367 M |
| Feb. 15, 2024 | 4.979 M |
| Jan. 31, 2024 | 5.439 M |
EPS Surprise
| Period | Estimate | Actual | Surprise |
|---|---|---|---|
| 12/31/2023 | 0.23 | 0.07 | -69.94% |
| 09/30/2023 | 0.44 | 0.30 | -32.39% |
| 06/30/2023 | 0.10 | 0.31 | 203.92% |
| 03/31/2023 | -0.25 | 0.02 | 108.15% |
| 12/31/2022 | -0.84 | -0.65 | 22.25% |
AMLX Basic Data
| Sector | Healthcare | Industry | Biotechnology |
| Shares Outstanding | 67.782M | Shares Float | 50.938M |
| Short Float | 6.007M | Market Cap | 135.56M |
| Institution ownership | 0.00% | Insider ownership | 14.242% |
| Earnings Date | 05/09/2024 AMC | Cash Per Share | ? |
| Trailing EPS | 0.70 | Forward EPS | -0.77 |